Advertisement

Journal of Community Health

, Volume 37, Issue 6, pp 1127–1135 | Cite as

Awareness, Acceptability and Uptake of Human Papilloma Virus Vaccine Among Cameroonian School-Attending Female Adolescents

  • Claudine Akono Ayissi
  • Richard G. Wamai
  • Geofrey O. Oduwo
  • Stacey Perlman
  • Edith Welty
  • Thomas Welty
  • Simon Manga
  • Javier Gordon Ogembo
Original Paper

Abstract

The purpose of this study is to assess awareness, knowledge and beliefs about HPV, cervical cancer HPV vaccine and willingness to vaccinate among adolescent females aged 12–26 years at clinics and schools in the North West Region of Cameroon where the Cameroon Baptist Convention Health Services (CBCHS) conducted a sensitization and education campaign. A questionnaire survey was administered among female adolescents in schools and clinics. Descriptive statistics including frequencies, percentages and proportions were generated for independent variables and bivariate analyses (Chi square test) were used to assess the relationship between independent and outcome variables. Data were analyzed using SAS Version 9.2. Out of a sample of 650 adolescent girls 553 willingly participated in this anonymous survey. Awareness of HPV (86.8%), cervical cancer (82.3%), and prevention of HPV infections through vaccination (75.9%) was significantly higher than in previous studies conducted in Cameroon and other developing countries. Higher perceptions of risk were associated with being sexually active (p = 0.0013), age (p = 0.0031) and level of education (p = 0.0274). Age and educational level were associated with HPV knowledge (p = 0.007 and p = 0.0008), respectively. The mean level of interest in HPV vaccination was 4.0 (SD = 1.27), which is above the mean. Our data indicate high awareness about HPV, cervical cancer and HPV vaccine among adolescents, and interest in receiving the vaccine and learning about the disease. CBCHS’ community education strategy effectively raised acceptability and generated demand for HPV vaccine, making it a potential model for HPV immunization in Cameroon and other developing countries.

Keywords

HPV Cervical cancer Attitudes Vaccine Adolescents Cameroon 

Notes

Acknowledgments

We thank the CBCHS for their support during the data collection fieldwork and the parents and school head teachers for allowing us to enroll their students in the study.

References

  1. 1.
    Anorlu, R. I. (2008). Cervical cancer: The sub-Saharan African perspective. Reprod Health Matters, 16(32), 41–49.PubMedCrossRefGoogle Scholar
  2. 2.
    Parkin, D. M., Ferlay, J., Hamdi-Cherif, M., Sitas, F., Thomas, J., Wabinga, H, et al. (2003). Cancer in Africa: Epidemiology and prevention. IARC Press (IARC Scientific Publication No. 153).Google Scholar
  3. 3.
    Denny, L. (2005). The prevention of cervical cancer in developing countries. BJOG, 112(9), 1204–1212.PubMedCrossRefGoogle Scholar
  4. 4.
    Farmer, P., Frenk, J., Knaul, F. M., Shulman, L. N., Alleyne, G., Armstrong, L., et al. (2010). Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet, 376(9747), 1186–1193.PubMedCrossRefGoogle Scholar
  5. 5.
    Agosti, J. M., & Goldie, S. J. (2007). Introducing HPV vaccine in developing countries–key challenges and issues. New England Journal of Medicine, 356(19), 1908–1910.PubMedCrossRefGoogle Scholar
  6. 6.
    WHO. (2010). WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Cameroon. Summary Report 2010. www.who.int/hpvcentre. Accessed 28 Aug 2011.
  7. 7.
    World Health Organization. (2002). Cervical cancer screening in developing countries: Report of a WHO consultation. Geneva: World Health Organization.Google Scholar
  8. 8.
    Durst, M., Gissmann, L., Ikenberg, H., & Zur Hausen, H. (1983). A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences, 80(12), 3812.CrossRefGoogle Scholar
  9. 9.
    WHO. (2009). Human papillomavirus vaccines: WHO position paper. WHO Weekly epidemiological record, 84(15), 117–132.Google Scholar
  10. 10.
    Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., et al. (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine, 356(19), 1928–1943.PubMedCrossRefGoogle Scholar
  11. 11.
    Tan, J., Farrell, L., & Allen, D. G. (2010). The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey. Australian and New Zealand Journal of Obstetrics and Gynaecology, 50(5), 472–477.PubMedCrossRefGoogle Scholar
  12. 12.
    Cutts, F. T., Franceschi, S., Goldie, S., Castellsague, X., de Sanjose, S., Garnett, G., et al. (2007). Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization, 85(9), 719–726.PubMedCrossRefGoogle Scholar
  13. 13.
    Munoz, N., Bosch, F. X., Castellsague, X., Diaz, M., de Sanjose, S., Hammouda, D., et al. (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. International Journal of Cancer, 111(2), 278–285.CrossRefGoogle Scholar
  14. 14.
    Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahe, C., et al. (2005). Cost-effectiveness of cervical-cancer screening in five developing countries. New England Journal of Medicine, 353(20), 2158–2168.PubMedCrossRefGoogle Scholar
  15. 15.
    Wright, T. C, Jr, Denny, L., Kuhn, L., Pollack, A., & Lorincz, A. (2000). HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA, 283(1), 81–86.PubMedCrossRefGoogle Scholar
  16. 16.
    Doh, A. S., Nkele, N. N., Achu, P., Essimbi, F., Essame, O., & Nkegoum, B. (2005). Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon. International Journal of Gynaecology and Obstetrics, 89(2), 167–173.PubMedCrossRefGoogle Scholar
  17. 17.
    Denny, L., Quinn, M., & Sankaranarayanan, R. (2006). Chapter 8: Screening for cervical cancer in developing countries. Vaccine, 24(Suppl 3), S3/71–S3/77.Google Scholar
  18. 18.
    Mbakop, A., Yomi, J., Yankeum, J., & Nkegoum, B. (1997). Mouelle Sone A: [Cancer localisation in men and women aged over 50 in Cameroon]. Bulletin du Cancer, 84(12), 1119–1122.PubMedGoogle Scholar
  19. 19.
    Tebeu, P. M., Major, A. L., Rapiti, E., Petignat, P., Bouchardy, C., Sando, Z., et al. (2008). The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon. International Journal of Gynecological Cancer, 18(4), 761–765.PubMedCrossRefGoogle Scholar
  20. 20.
    Atashili, J., Smith, J. S., Adimora, A. A., Eron, J., Miller, W. C., & Myers, E. (2011). Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: A simulation. PLoS ONE, 6(4), e18527.PubMedCrossRefGoogle Scholar
  21. 21.
    De Vuyst, H., Lillo, F., Broutet, N., & Smith, J. S. (2008). HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. European Journal of Cancer Prevention, 17(6), 545–554.PubMedCrossRefGoogle Scholar
  22. 22.
    Hawes, S. E., Critchlow, C. W., Sow, P. S., Toure, P., N’Doye, I., Diop, A., et al. (2006). Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. Journal of the National Cancer Institute, 98(2), 100–109.PubMedCrossRefGoogle Scholar
  23. 23.
    Massad, L. S., Ahdieh, L., Benning, L., Minkoff, H., Greenblatt, R. M., Watts, H., et al. (2001). Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndromes, 27(5), 432–442.PubMedCrossRefGoogle Scholar
  24. 24.
    Mogtomo, M. L., Malieugoue, L. C., Djiepgang, C., Wankam, M., Moune, A., & Ngane, A. N. (2009). Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer, 4, 9.PubMedCrossRefGoogle Scholar
  25. 25.
    Schuman, P., Ohmit, S. E., Klein, R. S., Duerr, A., Cu-Uvin, S., Jamieson, D. J., et al. (2003). Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Journal of Infectious Diseases, 188(1), 128–136.PubMedCrossRefGoogle Scholar
  26. 26.
    McCarey, C., Pirek, D., Tebeu, P. M., Boulvain, M., Doh, A. S., & Petignat, P. (2011). Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Women’s Health, 11(1), 45.PubMedCrossRefGoogle Scholar
  27. 27.
    Wamai, R., Ayissi, C. A., Oduwo, G. O., Perlman, S. M., Welty, E., Manga, S., et al. (2012). Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon. Journal of Community Health [Epub ahead of print].Google Scholar
  28. 28.
    World Health Organization. (2006). Promotion RHWHOCDH: Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO.Google Scholar
  29. 29.
    Likert, R. (1932). A technique for the measurement of attitudes. Archives of psychology, 22(140), 1–55.Google Scholar
  30. 30.
    Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., et al. (2009). HPV screening for cervical cancer in rural India. New England Journal of Medicine, 360(14), 1385–1394.PubMedCrossRefGoogle Scholar
  31. 31.
    Parham, G. P., & Mwanahammuntu, M. (2004). Building a cervical cancer prevention program into the HIV care and treatment infrastructure in Zambia. From the Ground Up, 2, 429–445.Google Scholar
  32. 32.
    Parham, G. P., Mwanahamuntu, M. H., Sahasrabuddhe, V. V., Westfall, A. O., King, K. E., Chibwesha, C., et al. (2010). Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Therapy, 4(6), 713–722.CrossRefGoogle Scholar
  33. 33.
    Cremer, M., Jamshidi, R., Muderspach, L., Tsao-Wei, D., Felix, J., & Blumenthal, P. (2005). Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador. International Journal of Gynecology & Obstetrics, 91(1), 42–46.CrossRefGoogle Scholar
  34. 34.
    Blumenthal, P. D., Gaffikin, L., Deganus, S., Lewis, R., Emerson, M., & Adadevoh, S. (2007). Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. American Journal of Obstetrics and Gynecology, 196(4):407 e401–408; discussion 407 e408-409.Google Scholar
  35. 35.
    Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008). Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med, 5(6), e132.PubMedCrossRefGoogle Scholar
  36. 36.
    Mwanahamuntu, M. H., Sahasrabuddhe, V. V., & Parham, G. P. (2009). HPV screening for cervical cancer in rural India. The New England Journal of Medicine, 361(3):305; author reply 306.Google Scholar
  37. 37.
    Becker-Dreps, S., Otieno, W. A., Brewer, N. T., Agot, K., & Smith, J. S. (2010). HPV vaccine acceptability among Kenyan women. Vaccine, 28(31), 4864–4867.PubMedCrossRefGoogle Scholar
  38. 38.
    DiAngi, Y. T., Panozzo, C. A., Ramogola-Masire, D., Steenhoff, A. P., & Brewer, N. T. (2011). A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana. PLoS ONE, 6(10), e25481.PubMedCrossRefGoogle Scholar
  39. 39.
    Iliyasu, Z., Abubakar, I., Aliyu, M., & Galadanci, H. (2010). Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. Journal of Obstetrics and Gynaecology, 30(8), 857–862.PubMedCrossRefGoogle Scholar
  40. 40.
    Coleman, M. A., Levison, J., & Sangi-Haghpeykar, H. (2011). HPV vaccine acceptability in Ghana, West Africa. Vaccine, 29(23), 3945–3950.Google Scholar
  41. 41.
    Francis, S. A., Nelson, J., Liverpool, J., Soogun, S., Mofammere, N., & Thorpe, R. J, Jr. (2010). Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine, 28(50), 8026–8032.PubMedCrossRefGoogle Scholar
  42. 42.
    Katahoire, R., Jitta, J., Kivumbi, G., Murokora, D., Arube, W. J., Siu, G., et al. (2010) An assessment of the readiness for introduction of the HPV vaccine in Uganda. African Journal of Reproductive Health, 12(3).Google Scholar
  43. 43.
    Mupepi, S. C., Sampselle, C. M., & Johnson, T. R. B. (2011). Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. Journal of Women’s Health, 20(6), 943–952.PubMedCrossRefGoogle Scholar
  44. 44.
    Cremer, M. L., Conlisk, E., & Felix, J. C. (2009) HPV screening for cervical cancer in rural India. The New England journal of medicine, 361(3):305; author reply 306.Google Scholar
  45. 45.
    Dell, D. L., Chen, H., Ahmad, F., & Stewart, D. E. (2009) Knowledge about human papillomavirus among adolescents. Obstetrics & gynecology, 96(5, Part 1):653.Google Scholar
  46. 46.
    Woodhall, S. C., Lehtinen, M., Verho, T., Huhtala, H., Hokkanen, M., & Kosunen, E. (2007). Anticipated acceptance of HPV vaccination at the baseline of implementation: A survey of parental and adolescent knowledge and attitudes in Finland. Journal of Adolescent Health, 40(5), 466–469.PubMedCrossRefGoogle Scholar
  47. 47.
    Di Giuseppe, G., Abbate, R., Liguori, G., Albano, L., & Angelillo, I. (2008). Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. British Journal of Cancer, 99(2), 225–229.PubMedCrossRefGoogle Scholar
  48. 48.
    Blumenthal, J., Frey, M. K., Worley, M. J., Tchabo, N. E., Soren, K., & Slomovitz, B. M. (2012). Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City. Journal of Oncology. doi: 10.1155/2012/904034.
  49. 49.
    Gellin, B. G., Maibach, E. W., & Marcuse, E. K. (2000). Do parents understand immunizations? A national telephone survey. Pediatrics, 106(5), 1097–1102.PubMedCrossRefGoogle Scholar
  50. 50.
    Jakeway, C. C., LaRosa, G., Cary, A., & Schoenfisch, S. (2008). The role of public health nurses in emergency preparedness and response: A position paper of the association of state and territorial directors of nursing. Public Health Nursing, 25(4), 353–361.PubMedCrossRefGoogle Scholar
  51. 51.
    Lindley, M. C., Boyer-Chu, L., Fishbein, D. B., Kolasa, M., Middleman, A. B., Wilson, T., et al. (2008). The role of schools in strengthening delivery of new adolescent vaccinations. Pediatrics, 121(Suppl 1), S46–S54.PubMedCrossRefGoogle Scholar
  52. 52.
    Nkowane, A. M., Boualam, L., Haithami, S., El Sayed el, T. A., & Mutambo, H. (2009). The role of nurses and midwives in polio eradication and measles control activities: a survey in Sudan and Zambia. Human Resources for Health, 7, 78.PubMedCrossRefGoogle Scholar
  53. 53.
    Robinson, J. S., Burkhalter, B. R., Rasmussen, B., & Sugiono, R. (2001). Low-cost on-the-job peer training of nurses improved immunization coverage in Indonesia. Bulletin of the World Health Organization, 79(2), 150–158.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Claudine Akono Ayissi
    • 1
  • Richard G. Wamai
    • 4
  • Geofrey O. Oduwo
    • 5
  • Stacey Perlman
    • 1
  • Edith Welty
    • 3
  • Thomas Welty
    • 3
  • Simon Manga
    • 3
  • Javier Gordon Ogembo
    • 1
    • 2
  1. 1.College of Professional StudiesNortheastern UniversityBostonUSA
  2. 2.Harvard Medical School and Beth Israel Medical Deaconess CenterBostonUSA
  3. 3.Cameroon Baptist Convention Health Services (CBCHS)BamendaCameroon
  4. 4.Department of African American StudiesNortheastern UniversityBostonUSA
  5. 5.Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) Research and Public Health CollaborationKisumuKenya

Personalised recommendations